21 May 2019
Transforming DCB strategy: sirolimus-coated balloon with Nanolute technology
Sponsored by Concept Medical, INC
Chairpersons:
A. Abizaid, P. Serruys
Panellists:
B. Cortese, C.K. Naber
Summary
Consult this session on DCB strategy to learn more about the use of sirolimus-coated balloon with Nanolute technology, and to understand its benefits and its future applications in coronary interventions, thanks to the insight from pre-clinical evaluation, various clinical cases and FDA study.
Learning Objectives
- To learn about the use of sirolimus-coated balloon in select indication with clinical outcomes
- To learn about NANOLUTE technology applications in drug delivery and its benefits
- To discuss the future and scope of sirolimus-coated balloon in coronary interventions
